CAR T-cell Therapy

This week’s news roundup highlights a web-based tool that analyzes the dual genome nature of mitochondrial disease, a CHOP STAT Madness competitor, and more.

With funding from the National Cancer Institute’s Childhood Cancer Data Initiative, CHOP researchers are identifying new immunotherapy targets.

Our research news roundup highlights the improvements made in CAR therapies through structural biology discoveries and cost reduction strategies.

Leyuan Ma, PhD, our October Faculty Spotlight, uses his passion for immune engineering to develop novel therapeutic treatments for cancer.

Cassie Kline, MD, MAS, and Jessica Foster, MD, received a seed grant to study CAR T-cell and radiotherapy for diffuse midline gliomas.

In this Q&A, Drs. Teachey and Diorio discuss their partnership and research of a novel CAR T-cell therapy for one of the most common pediatric cancers.

This week's news roundup features an outstanding science award, Highly Cited Researchers, and STAT Wunderkinds, along with new research about cancer risk with birth defects, epilepsy, and acute myeloid leukemia.

The Emerging Innovators at CHOP Research Institute cover a variety of scientific disciplines.

This week’s In the News features endocrinology research, news on gene therapy in blood disorders, CAR T-cell therapy, and more.

Neuro-oncologist Jessica Foster MD, is investigating chimeric antigen receptor (CAR) T-cell therapy for brain tumors.